Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02316834
Title POSITION: A PilOt Study of InducTion PARP InhibitiON in Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center, BioMarin Pharmaceutical
Indications

fallopian tube carcinoma

ovary serous adenocarcinoma

peritoneal carcinoma

Therapies

Talazoparib

Age Groups: adult


No variant requirements are available.